Showing 901 - 920 results of 106,643 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((nm decrease) OR (a decrease)) ))', query time: 1.65s Refine Results
  1. 901
  2. 902

    Tonic nM DA stabilizes the timing of LP activity over the short term. by Wulf-Dieter C. Krenz (693267)

    Published 2015
    “…<p><b>(A) Pyloric output is altered by 1mM 4AP</b>. Representative experiments showing the motor output at three time points for a preparation continuously superfused with 1mM 4AP (blue) or 1mM 4AP + 5nM DA (green) beginning at t = 0. …”
  3. 903

    Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1. by Rajesh Jayachandran (542641)

    Published 2014
    “…Scale bar, 2 microns. Data shown are mean values ± SD, <i>p</i><0.01. (C) Hippocampal neurons were labeled using anti-vGLUT1 and anti-vGAT antibodies, followed by Alex Fluor 488 or 568 labeled secondary antibodies, respectively. …”
  4. 904

    Data from the behavioural experiments described in the paper: Decreased olfactory discrimination is associated with impulsivity in healthy volunteers by Aleksandra Herman (4465258)

    Published 2018
    “…<b>Data for paper appearing in Scientific Reports</b><div><br></div><div>Excel workbooks containing data collected and analysed in the paper: "Decreased olfactory discrimination is associated with impulsivity in healthy volunteers". …”
  5. 905

    Length-Dependent Convergence and Saturation Behavior of Electrochemical, Linear Optical, Quadratic Nonlinear Optical, and Cubic Nonlinear Optical Properties of Dipolar Alkynylruthe... by Bandar Babgi (2360545)

    Published 2009
    “…The syntheses of <i>trans</i>-[Ru{4,4′-CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>}Cl(dppm)<sub>2</sub>] (<b>19</b>), <i>trans</i>-[Ru{4,4′,4′′-CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>}Cl(dppm)<sub>2</sub>] (<b>20</b>), <i>trans</i>-[Ru{4,4′,4′′,4′′′-CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>}Cl(dppe)<sub>2</sub>] (<b>21</b>), <i>trans</i>-[Ru{4,4′,4′′,4′′′-CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>}Cl(dppm)<sub>2</sub>] (<b>22</b>), <i>trans</i>-[Ru{4,4′,4′′,4′′′-CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>}Cl(dppm)<sub>2</sub>] (<b>23</b>), and <i>trans</i>-[Ru{4,4′,4′′,4′′′,4′′′′-CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>4</sub>CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>2</sub>[2,5-(OEt)<sub>2</sub>]CCC<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>}Cl(dppm)<sub>2</sub>] (<b>24</b>) are reported, together with those of precursor alkynes, complexes with the donor−π-bridge−acceptor formulation that affords efficient quadratic and cubic NLO compounds; the identity of <b>19</b> was confirmed by a structural study. …”
  6. 906
  7. 907

    Decreased 11ß-HSD1 protein level by IGF-I overexpression <i>in vivo</i> and a direct treatment with IGF-I. by Subrata Chowdhury (787208)

    Published 2015
    “…<p><b>A</b>. IGF-I overexpression decreased the levels of 11ß-HSD1 in pancreatic islets, liver and visceral fat, shown in Western blots. …”
  8. 908

    Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study by Jon Jarløv Rasmussen (2993427)

    Published 2016
    “…</p><p>Methods</p><p>This study had a cross-sectional case-control design and involved 37 current AAS abusers, 33 former AAS abusers (mean (95%CI) elapsed duration since AAS cessation: 2.5 (1.7; 3.7) years) and 30 healthy control participants. …”
  9. 909
  10. 910
  11. 911
  12. 912

    Decreased reactive gliosis following ES delivered 5d post-demyelination. by Nikki A. McLean (643606)

    Published 2014
    “…Contralateral intact control nerves displayed only minimal GFAP IF (A). However 5d post-lysophosphatidyl choline (LPC)/FG injection there was a marked increase in GFAP IF (B). …”
  13. 913

    DataSheet_1_Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.docx by Shunzhang Yu (12340927)

    Published 2022
    “…HCC incidences in males at younger age groups (age <50 years old), particularly in those with age <34 groups, showed an accelerating decrease over time, whereas HCC incidences significantly declined in the female population across all age groups except for those under 19 years of age. …”
  14. 914

    DataSheet_1_Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.docx by Shunzhang Yu (12340927)

    Published 2022
    “…HCC incidences in males at younger age groups (age <50 years old), particularly in those with age <34 groups, showed an accelerating decrease over time, whereas HCC incidences significantly declined in the female population across all age groups except for those under 19 years of age. …”
  15. 915
  16. 916

    Decreased HATL5 expression in esophageal and cervical carcinomas. by Gregory S. Miller (519005)

    Published 2014
    “…Staining intensities were determined as described in Material and Methods. (<b>A</b>) In esophageal squamous cell carcinomas, a highly significant decrease in staining intensity (P<0.0001) was observed between normal tissues and each of the two groups of cancer tissues; grades I-II and grade III, respectively. …”
  17. 917

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
  18. 918

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  19. 919
  20. 920

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Outpatient visit frequency also significantly declined from 11.5 ± 4.3 visits in the year before surgery to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g004" target="_blank">Fig 4</a>).…”